Applying an Improved Stacking Ensemble Model to Predict the Mortality of ICU Patients with Heart Failure

Chih-Chou Chiu1, Chung-Min Wu1, Te-Nien Chien2

  • 1Department of Business Management, National Taipei University of Technology, Taipei 106, Taiwan.

Insights

This study developed an accurate heart failure (HF) mortality prediction model for ICU patients. The model achieved 95.25% accuracy, identifying key predictors like platelets and glucose for better patient care.

Area of Science:

  • Medical Informatics
  • Clinical Prediction Models
  • Cardiovascular Research

Background:

  • Cardiovascular diseases, particularly heart failure (HF), are leading global causes of mortality.
  • Intensive Care Units (ICUs) manage high-risk HF patients, necessitating precise mortality prediction for timely interventions.
  • Accurate prediction of mortality risk in ICU patients with HF is crucial for resource allocation and patient management.

Purpose of the Study:

  • To develop and validate an integrated stacking model for precise prediction of mortality in Intensive Care Unit (ICU) patients with heart failure (HF).
  • To identify key clinical features influencing HF patient mortality prediction within the first 24 hours of ICU admission.

Main Methods:

  • Utilized data from 6699 HF patients in the MIMIC-III database, focusing on vital signs and tests within the first 24 hours of ICU admission.
  • Employed an integrated stacking model with six first-level classifiers (RF, SVC, KNN, LGBM, Bagging, Adaboost) and a second-level classifier for enhanced prediction accuracy.
  • Evaluated model performance using accuracy and Area Under the Receiver Operating Characteristic Curve (AUROC).

Main Results:

  • The proposed integrated stacking model achieved a high accuracy of 95.25% and an AUROC of 82.55% in predicting HF patient mortality.
  • Key clinical features significantly impacting mortality prediction included platelets, glucose, and blood urea nitrogen.
  • The model demonstrated outstanding capability and efficiency in predicting mortality risk for HF patients in the ICU.

Conclusions:

  • The developed integrated stacking model offers a highly accurate and efficient tool for predicting mortality in ICU patients with heart failure.
  • Identifying critical predictive features like platelets, glucose, and BUN enhances clinical understanding and supports optimized healthcare resource utilization.
  • This predictive capability facilitates timely and appropriate medical care for high-risk HF patients, potentially improving outcomes.

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
27
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
19
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
43
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
37
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
25